Please login to the form below

I have forgotten my password

IBD

This page shows the latest IBD news and features for those working in and with pharma, biotech and healthcare.

Finch Therapeutics bags $53m for microbiome therapies

investigational IBD medicines.

Latest news

M&F Health, 90TEN and Sanofi among big winners at Communiqué Awards

Sponsored by Cloud Talk. Winner: LOGIC IBD Nurse Education and Recognition Event.
Latecomer Lilly preps its IL-23 drug for Crohn’s disease

Tremfya also has data suggesting it works in Stelara-resistant psoriasis. Lilly’s antibody is still in phase 3 for psoriasis, well behind the leaders, but IBD presents a greater opportunity
Finch’s microbiota drug for C. diff gets FDA breakthrough status

Finch's CEO Mark Smith. Led by CEO Mark Smith, the company also has a two-year-old deal with Takeda to develop a microbiota treatment for irritable bowel disease (IBD).
BMS to test Vedanta’s bacterial therapy with Opdivo

The two companies have started treating patients in a phase 1 trial of VE202, another bacterial consortium aimed at treating inflammatory bowel disease (IBD). ... VE202 is based on the idea that IBD patients are deficient in certain Clostridia species in
Communiqué: big wins for obesity and sugar tax campaigners

Specialist healthcare communications group Sciterion (pictured below) won the Excellence in Communications via a Live Event or Stand-Alone Activity accolade for its Live Multi-site National IBD Meeting. ... Meanwhile, Aurora Healthcare Communications’

More from news
Approximately 11 fully matching, plus 32 partially matching documents found.

Latest Intelligence

Gut instincts lead Takeda to GI pipeline success

It has been a game changer for IBD patients and the EMA decision means that they have greater choice. ... Projects that address gut inflammation beyond IBD are focused on coeliac disease, acute pancreatitis and short bowel syndrome.
Case study: Logic IBD Nurse Education Day and Recognition Event

The solution was a dual-aspect meeting: The ‘LOGIC IBD Nurse Education Day and Recognition Event’. ... IBD nurses had limited support with personal development and raising their profile within their hospital/Trust.
Case study: IBD Registry Roadshow

It was originally planned to run alongside a successful national IBD Audit programme managed by the Royal College of Physicians (RCP). ... In 2015 NHS England announced it was pulling the Audit funding and recommended that future audits be incorporated
Deal Watch February 2017

The deal also includes a licence to AKB-5169 (formerly JNJ5169), an oral, preclinical stage compound for inflammatory bowel disease (IBD). . ... Joint venture. 286.3. Janssen/ Akebia Therapeutics. HIF-targeting candidates inc AKB-5169 for IBD (pc)
Deal Watch June 2016

IBD). PF-00547659 targets a gastrointestinal endothelial adhesion molecule known as mucosal addressin cell adhesion molecule 1 (MAdCAM-1) that binds to the α4β7 integrin on lymphocytes.

More from intelligence
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest appointments

Takeda strengthens leadership team with business unit director

Takeda UK has appointed Craig Adkins as its new business unit director for irritable bowel disease (IBD). .

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

July 2020: diversity and inclusion in clinical trials round-up

Asians. Health outcomes for IBD are poorer among African Americans vs white Americans. ... In some cultures, an IBD diagnosis is associated with stigma, which can impact the patient journey.
Lucid Group bolsters its senior client services team with two magical new hires

She has experience across several different therapy areas, including diabetes, rare diseases and IBD.
Lucid Group strengthens its scientific leadership and client service team with two new hires

Lizzie has previously worked in Global, European, and UK roles with experience in several therapy areas including immuno-oncology, CIA, CKD, oral contraception, IBD, and wound care.
IBD Registry appoints first CEO

The IBD Registry is familiar to many as the first UK-wide collection of anonymised adult and paediatric IBD data for prospective audit and research. ... Liz brings to the IBD Registry 20 years of executive and senior management experience from the
Pharma and NHS working together for patients - the IBD Registry Industry Working Group

Recently, we spoke to members of the IBD Registry Industry Working Group about what they’ve achieved in their first year, and whether or not it’s been worthwhile.

More from PMHub
Approximately 3 fully matching, plus 19 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Account Director – Creative Healthcare Communications: Competative

Healthcare Lead Copywriter: Competitive

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Healthcare Account Director: Competitive

Medical Editor: Competitive

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

Healthcare Senior Account Manager: Competitive

PMHub

Add my company

Madmicrobe Studios

MadMicrobe is an award-winning team of certified medical illustrators creating animations that draw audiences into a world of suspense, excitement,...

Latest intelligence

The pandemic preparedness paradox: Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Sourcing R&D innovation: why pharma companies need to evolve their business models: Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?: 2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...